Improving Health Literacy in Psoriasis: Communication, Compassion, Respect
Health literacy in psoriasis varies widely and is affected by many variables, from socioeconomics to geography.
Psoriasis
PSORIASIS
FEATURE ARTICLE
LATEST NEWS
Mirikizumab Safe, Efficacious for Treating Plaque Psoriasis in Phase 2 Study
Phase 2 study results showed that mirikizumab-treated patients had significantly higher efficacy compared to placebo, with comparable safety profiles.
GRADE Evaluation of Systemic Therapies for Psoriatic Arthritis
Investigators conducted a systemic review to examine the safety and efficacy of interventions for the treatment of psoriatic arthritis.
Screening Tool Identifies Psoriatic Arthritis in Patients With Psoriasis
The investigators sought to evaluate the risk for possible undiagnosed psoriatic arthritis in patients with psoriasis.
Examining the Potential Benefits of Secukinumab in Palmoplantar Pustular Psoriasis Treatment
Secukimumab may be an effective treatment option for patients with moderate to severe palmoplantar pustular psoriasis.
Recommendations for Nail Psoriasis in Adults With No or Mild Skin Psoriasis
A consensus group offers practical recommendations to treat nail psoriasis in patients with no skin psoriasis or with mild skin lesions with no indication for a systemic treatment.
Plasma TNF-α, Adiponectin Levels Influence Risk for Psoriatic Arthritis, Psoriasis
The investigators sought to determine whether TNF-α and adiponectin levels might play a role in differentiating psoriatic arthritis from psoriasis.
Metformin Safe for Patients With Type 2 Diabetes and Psoriasis
Metformin can be safely prescribed to patients with diabetes and psoriasis.
Age, Race Impact Atherosclerotic Risk With Psoriasis
Some subgroups of patients with psoriasis are at greater risk for atherosclerotic cardiovascular disease.
Incidental Findings on PET Scan Common Among Patients With Psoriasis
Incidental findings were defined as uncovering a potentially clinically significant image in an asymptomatic patient.
Tremfya One-Press Patient-Controlled Injector Approved for Patients With Moderate-to-Severe Plaque Psoriasis
The FDA has approved Tremfya (guselkumab; Janssen) One-Press, a single-dose patient-controlled injector for the treatment of moderate-to-severe plaque psoriasis in adults.
Want to read more?
Please login or register first to view this content.
Next post in Psoriasis
